New vaccine technologies: Covid-19 and mRNA platforms to treat cancer and infectious diseases: a regulatory and economic analysis
Pizziconi, Alice (A.A. 2022/2023) New vaccine technologies: Covid-19 and mRNA platforms to treat cancer and infectious diseases: a regulatory and economic analysis. Tesi di Laurea in Markets, regulations and law, Luiss Guido Carli, relatore Luca Arnaudo, pp. 97. [Master's Degree Thesis]
|
PDF (Full text)
Download (2MB) | Preview |
Abstract/Index
The pharmaceutical industry. How it works. Pharmaceuticals is the largest R&D investment in the world. Great progress with precision medicine resulting from synergies between science and technology. Pharmaceutical industry in Italy: increasingly committed to research. High competitiveness: a unique business mix in Europe and the strength of pharmaceutical specialisations in Italy. The impact of Covid-19 on pharmaceuticals and the economy. Vaccines and prevention. Vaccines are crucial for the health and sustainability of the national health system. Types of vaccines. Vaccine regulation: a little bit of historical background. The vaccine law. The Covid-19 vaccines. The first steps toward an mRNA vaccine. What they are and how they work. Production and supply of Covid-19 vaccines. Covid-19 vaccines: development, evaluation, approval and monitoring. Patents and regulation: a general overview. Patents and regulation: the Covid-19 case. Pharmaceutical inventions and the complex relationship between industrial property rights and health protection. Competition in the regulatory and economic landscape of Covid-19 vaccines. Economic analysis of Covid-19 vaccines. Covid-19 related profits. Covid-19 vaccine companies and the subsidies from governments. Covid-19 vaccine companies and the profit spending. Biopharma’s stock market winners in 2022, the flotations fail and venture investments. The beginning of a new era: next-generation therapeutics, with the contribution of Dr Rino Rappuoli. Relevant mRNA vaccine developments: infectious diseases and cancer. The regulatory and legislative situation and perspectives, with the contribution of Dr Rino Rappuoli. The economic highlights of this new technology, with the contribution of Dr Rino Rappuoli. Future challenges and opportunities for the mRNA vaccines, with the contribution of Dr Rino Rappuoli.
References
Bibliografia: pp. 78-83.
| Thesis Type: | Master's Degree Thesis |
|---|---|
| Institution: | Luiss Guido Carli |
| Degree Program: | Master's Degree Programs > Master's Degree Program in Management, English language (LM-77) |
| Chair: | Markets, regulations and law |
| Thesis Supervisor: | Arnaudo, Luca |
| Thesis Co-Supervisor: | Bruni, Elena |
| Academic Year: | 2022/2023 |
| Session: | Summer |
| Deposited by: | Alessandro Perfetti |
| Date Deposited: | 29 Jan 2024 14:52 |
| Last Modified: | 29 Jan 2024 14:52 |
| URI: | https://tesi.luiss.it/id/eprint/37788 |
Downloads
Downloads per month over past year
Repository Staff Only
 |
View Item |
